Sentence examples for receiving acts from inspiring English sources

After 15 months of the intervention, this fraction increased to 42%, with 9% of those receiving ACTs obtaining them from the subsidized shops (Sabot et al. 2009a, b).

Despite subsequent decreases in the unit price of ACTs, the average cost of anti-malarial drugs further increased by 2008 ($0.85) because all patients were receiving ACTs by that year.

Before the national scale up, household survey results indicated that only 8% of anti-malarial recipients received ACTs (Yeung et al. 2011); surveys unrelated specifically to the subsidy found 13% receiving ACTs in 2006 (PSI 2006), 65% in 2009 (ACTwatch Group, Population Services International 2009) and 68% in 2011 (ACTwatch Group and Population Services International 2011).

3 Among children treated with any antimalarial drug, the percentage receiving ACTs varies across countries from < 5% to > 90%. 4 A crucial factor contributing to low coverage of prompt and effective malaria treatment is the weakness of national health systems to deliver interventions in most low income countries.

Two of these experiments compared household survey responses regarding the fraction of febrile episodes treated with ACTs (Kangwana et al. 2011; Cohen et al. 2012a, b), while the other two compared the fraction of anti-malarial purchasers receiving ACTs vs other anti-malarials (Sabot et al. 2009a, b; Cohen et al. 2010; Talisuna et al. 2012).

These were more frequent in groups receiving Act-HIB + ViscoGel, while other AEs were recorded at similar frequency in Act-HIB and Act-HIB + ViscoGel groups.

Patients receiving ACT make small improvements in their QoL and ACT may help to solve some of their needs.

Among these studies, appropriate treatment by the CHWs was high (median = 97.7% RDT-positive patients receiving ACT; IQR = 92.7 99.3% 18, 30, 32– 37, 37 and median = 8.4% of RDT-negative patients receiving ACT; IQR = 4.6 15.5%).

In conclusion, patients receiving ACT make small improvements in their QoL and ACT may help to solve some of their needs.

The change in design in 2008 to all children receiving ACT antimalarial treatment did not affect the analysis of the primary outcome.

A pharmacokinetic study published in 2005, involving 31 patients receiving Act D, indicated a high level of inter-patient variability in Act D exposure among patients on similar dosage regimens.